Clinical trial
Time to Relapse During Treatment With Divalproex vs. Lamotrigine for Bipolar Disorder
NCT00451542 is registered in ClinicalTrials.gov with Tuscaloosa Research & Education Advancement Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Time to Relapse During Treatment With Divalproex vs. Lamotrigine for Bipolar Disorder
- Lead sponsor
- Tuscaloosa Research & Education Advancement Corporation
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 1, 2006
- Completion date
- February 1, 2008
- Enrollment
- 1,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.